摘要背景本研究旨在成年2 型糖尿病患者中调查补充维生素D 治疗对辛伐他汀介导的运动后
心肺适应性以及骨骼肌线粒体含量变化的影响. 方法年龄介于25‐50 岁之间并且缺乏维生素D …

Introduction Although low vitamin D levels are associated with statin-associated muscle
symptoms (SAMS), it remains unclear if vitamin D supplementation leads to symptom …

BACKGROUND Statins are the leading lipid-lowering drugs, reducing blood cholesterol by
controlling its synthesis. Side effects are linked to the use of statins, in particular statin …

Background Myopathy is the most widely reported statin-associated adverse event. Several
studies have linked vitamin D deficiency with statin-related myopathy. Objective This meta …

Background: Statin therapy is a cornerstone of cardiovascular disease treatment and
prevention. Unfortunately, 7%–29% of statin-treated patients complain of muscular fatigue …

Introduction There is a multitude of evidence supporting the benefit of statin use in
cardiovascular disease; however, statin-induced myopathy is a major reason for statin …

Background: Treatment with HMG-CoA reductase inhibitors (statins) is often complicated by
muscle-related adverse effects (MAEs). Studies of the association between low plasma …

In their study of statin-associated muscle symptoms (SAMS) in 120 patients with previous
self-described SAMS, published in this issue of Atherosclerosis, Taylor et al.[1] carried out …

Background Vitamin D is suggested to reduce cardiovascular risk. Hypothesis Circulating
levels of plasma lipids and other cardiovascular risk factors may differ between statin …

Background and aims Low vitamin D (VITD) may contribute to statin-associated muscle
symptoms (SAMS). We examined the influence of baseline and change in VITD in patients …